ConductScience.org, home

Paper27166255

A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.

Gaudio E and 13 others. Oncotarget, 2016. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells. Papers, record 27166255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27166255

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.
PubMed
Journal
Oncotarget
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.7
iCite
Revised in PubMed
2026-01-27
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gaudio EEugenio
2Paduano FFrancesco
3Ngankeu AApollinaire
4Ortuso FFrancesco
5Lovat FFrancesca
6Pinton SSandra
7D'Agostino SSabrina
8Zanesi NNicola
9Aqeilan RIRami I
10Campiglia PPietro
11Novellino EEttore
12Alcaro SStefano
13Croce CMCarlo M
14Trapasso FFrancesco

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acid Anhydride HydrolasesMajor topic
Annexin A4Major topic
Antineoplastic Agents, PhytogenicMajor topic
Drug Resistance, NeoplasmMajor topic
Lung NeoplasmsMajor topic
Neoplasm ProteinsMajor topic
PaclitaxelMajor topic
Peptide FragmentsMajor topic
A549 Cells
Animals
Cell Membrane
Female
Genes, Tumor Suppressor
Humans
Mice
Mice, Nude
Protein Binding
Protein Transport
Xenograft Model Antitumor Assays
Bis(5'-adenosyl)triphosphatase

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R35 CA197706NCI NIH HHSUnited StatesR35CA197706PubMed and NIHNIH RePORTER
U01 CA152758NCI NIH HHSUnited StatesU01CA152758PubMed and NIHNIH RePORTER
U01 CA166905NCI NIH HHSUnited StatesU01CA166905PubMed and NIHNIH RePORTER

Download CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116231322FHIT protein enhances paclitaxel-induced apoptosis in lung cancer cells.Int J Cancer2006https://conductscience.org/library/papers/16231322PubMed
212649173Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines.Cancer Res2003https://conductscience.org/library/papers/12649173PubMed
326048190Annexin A4 and cancer.Clin Chim Acta2015https://conductscience.org/library/papers/26048190PubMed
412574506Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12574506PubMed
515145526Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination.Cancer Lett2004https://conductscience.org/library/papers/15145526PubMed
620331649Probing the alpha-helical structural stability of stapled p53 peptides: molecular dynamics simulations and analysis.Chem Biol Drug Des2010https://conductscience.org/library/papers/20331649PubMed
712507908Dysregulation of the annexin family protein family is associated with prostate cancer progression.Am J Pathol2003https://conductscience.org/library/papers/12507908PubMed
811245468Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells.Cancer Res2001https://conductscience.org/library/papers/11245468PubMed
911517343The tumor spectrum in FHIT-deficient mice.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11517343PubMed
108794732Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.Biochemistry1996https://conductscience.org/library/papers/8794732PubMed
1114630947Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/14630947PubMed
1212839965Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.Cancer Res2003https://conductscience.org/library/papers/12839965PubMed
1318071363Characterisation and protein expression profiling of annexins in colorectal cancer.Br J Cancer2008https://conductscience.org/library/papers/18071363PubMed
1423290009Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary.Hum Pathol2013https://conductscience.org/library/papers/23290009PubMed
1511917092Annexins: from structure to function.Physiol Rev2002https://conductscience.org/library/papers/11917092PubMed
1625517383Targeting mitochondria metabolism for cancer therapy.Nat Chem Biol2015https://conductscience.org/library/papers/25517383PubMed
1723627474Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation.ACS Chem Biol2013https://conductscience.org/library/papers/23627474PubMed
1822759068Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity.ACS Chem Biol2012https://conductscience.org/library/papers/22759068PubMed
1919935706Fhit regulates invasion of lung tumor cells.Oncogene2010https://conductscience.org/library/papers/19935706PubMed
2010959838Crystal structure of the worm NitFhit Rosetta Stone protein reveals a Nit tetramer binding two Fhit dimers.Curr Biol2000https://conductscience.org/library/papers/10959838PubMed

See all 45 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42882772Expression of Annexin A4 in Cancer: A Tissue Microarray Study Involving More than 17,600 Cancers from 148 Tumor Entities.Cancers (Basel)2026https://conductscience.org/library/papers/42882772PubMed
41230108Targeting ANXA4 to Overcome Cisplatin Resistance in Ovarian Cancer: A Bioinformatics and in Vitro Study.Onco Targets Ther2025https://conductscience.org/library/papers/41230108PubMed
40095055FOXD1-activated ANXA3 facilitates cisplatin resistance of lung cancer cells via promoting ANXA4 expression.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40095055PubMed
39712859The small molecule peptide ANXA114-26 inhibits ovarian cancer cell proliferation and reverses cisplatin resistance by binding to the formyl peptide receptors receptor.J Cell Commun Signal2025https://conductscience.org/library/papers/39712859PubMed
36936694Annexin A protein family: Focusing on the occurrence, progression and treatment of cancer.Front Cell Dev Biol2023https://conductscience.org/library/papers/36936694PubMed
36339705Editorial: Analytical devices based on immobilized macromolecules for structural and activity/affinity studies in drug discovery.Front Mol Biosci2022https://conductscience.org/library/papers/36339705PubMed
36289813The Tumour Suppressor Fhit Protein Activates C-Raf Ubiquitination and Degradation in Human Melanoma Cells by Interacting with Hsp90.Biomedicines2022https://conductscience.org/library/papers/36289813PubMed
36247003Pathobiological functions and clinical implications of annexin dysregulation in human cancers.Front Cell Dev Biol2022https://conductscience.org/library/papers/36247003PubMed
34912787Editorial: Protein-Protein Interactions: Drug Discovery for the Future.Front Chem2021https://conductscience.org/library/papers/34912787PubMed
34901149Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides.Front Mol Biosci2021https://conductscience.org/library/papers/34901149PubMed
33810523Annexin Animal Models-From Fundamental Principles to Translational Research.Int J Mol Sci2021https://conductscience.org/library/papers/33810523PubMed
31807177Expression levels and prognostic values of annexins in liver cancer.Oncol Lett2019https://conductscience.org/library/papers/31807177PubMed
28404875Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells.Oncotarget2017https://conductscience.org/library/papers/28404875PubMed
28052032A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis.Oncotarget2017https://conductscience.org/library/papers/28052032PubMed
27852977The Fhit protein: an opportunity to overcome chemoresistance.Aging (Albany NY)2016https://conductscience.org/library/papers/27852977PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27166255

GET https://conductscience.org/api/papers/v1/27166255/references?page=2